GB1205019A - Improvements in or relating to oral dosage forms - Google Patents
Improvements in or relating to oral dosage formsInfo
- Publication number
- GB1205019A GB1205019A GB5487566A GB5487566A GB1205019A GB 1205019 A GB1205019 A GB 1205019A GB 5487566 A GB5487566 A GB 5487566A GB 5487566 A GB5487566 A GB 5487566A GB 1205019 A GB1205019 A GB 1205019A
- Authority
- GB
- United Kingdom
- Prior art keywords
- plasticiser
- medicament
- dosage forms
- base material
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
Abstract
1,205,019. Oral dosage forms. STERWIN A.G. 7 Dec., 1967 [7 Dec., 1966], No. 54875/ 66. Heading A5B. A solid oral unit dosage form comprises a medicament, and 50-85% by weight of a pharmaceutically acceptable base material and 1-30% by wt of a plasticiser for said base material, the plasticiser and base material forming a mixture which is water-soluble, has a m.p. without charring or other decomposition between 35‹ and 90‹C and acts as a solvent for the medicament when in the molten state. The dosage forms may be prepared by dissolving the medicament in a melt of the base and plasticiser and allowing drops to fall through a cooling atmosphere on to a cool surface and allowing the mixture to solidify, usually yielding a form that is flat on one side and curved convexly on the other. Medicaments referred to are isoprenaline and its salts, alkaloids e.g. caffeine, glyceryl trinitrite, vitamins e.g. A, D or riboflavin, an aromatic mixture acting as a breath freshener and a sugar substitute e.g. saccharin. Suitable base materials include polyethylene glycols, and polyoxyethylene esters and ethers.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5487566A GB1205019A (en) | 1966-12-07 | 1966-12-07 | Improvements in or relating to oral dosage forms |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5487566A GB1205019A (en) | 1966-12-07 | 1966-12-07 | Improvements in or relating to oral dosage forms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1205019A true GB1205019A (en) | 1970-09-09 |
Family
ID=10472324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB5487566A Expired GB1205019A (en) | 1966-12-07 | 1966-12-07 | Improvements in or relating to oral dosage forms |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1205019A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012113564A1 (en) * | 2011-02-25 | 2012-08-30 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| US9180109B2 (en) | 2010-08-03 | 2015-11-10 | G. Pohl-Boskamp Gmbh & Co. Kg | Use of glyceryl trinitrate for treating traumatic edema |
| US9248099B2 (en) | 2012-05-31 | 2016-02-02 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| US10034850B2 (en) | 2013-11-29 | 2018-07-31 | G. Pohl-Boskamp Gmbh & Co. Kg | Sprayable aqueous composition comprising glyceryl trinitrate |
| US11166931B2 (en) | 2012-05-31 | 2021-11-09 | G. Pohl-Boskamp Gmbh & Co. Kg | Induction of arteriogenesis with an NO (nitric oxide) donor |
-
1966
- 1966-12-07 GB GB5487566A patent/GB1205019A/en not_active Expired
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9180109B2 (en) | 2010-08-03 | 2015-11-10 | G. Pohl-Boskamp Gmbh & Co. Kg | Use of glyceryl trinitrate for treating traumatic edema |
| US9693983B2 (en) | 2010-08-03 | 2017-07-04 | G. Pohl-Boskamp Gmbh & Co. Kg | Use of glyceryl trinitrate for treating traumatic edema |
| WO2012113564A1 (en) * | 2011-02-25 | 2012-08-30 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| US9101592B2 (en) | 2011-02-25 | 2015-08-11 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| AU2012219926B2 (en) * | 2011-02-25 | 2016-11-17 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| US9616023B2 (en) | 2011-02-25 | 2017-04-11 | G. Pohl-Boskamp Gmbh & Co. Kg | Stabilized granules containing glyceryl trinitrate |
| EP3354259A1 (en) * | 2011-02-25 | 2018-08-01 | G. Pohl-Boskamp GmbH & Co. KG | Stabilized granules containing glyceryl trinitrate |
| US9248099B2 (en) | 2012-05-31 | 2016-02-02 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| US9675552B2 (en) | 2012-05-31 | 2017-06-13 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| US11166931B2 (en) | 2012-05-31 | 2021-11-09 | G. Pohl-Boskamp Gmbh & Co. Kg | Induction of arteriogenesis with an NO (nitric oxide) donor |
| US10034850B2 (en) | 2013-11-29 | 2018-07-31 | G. Pohl-Boskamp Gmbh & Co. Kg | Sprayable aqueous composition comprising glyceryl trinitrate |
| US10987332B2 (en) | 2013-11-29 | 2021-04-27 | G. Pohl-Boskamp Gmbh & Co. Kg | Sprayable aqueous composition comprising glyceryl trinitrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES369368A1 (en) | 2-(6'-methoxynaphth-2'-yl)propylene oxide and 5'-halo derivatives | |
| ES2189803T3 (en) | PROCESS. | |
| IE40616B1 (en) | Apparatus for dispensing dosages of powdered medicaments by inhalation | |
| TR199500856A2 (en) | Pharmaceutical composition that is taken by breathing in ice. | |
| IL74707A0 (en) | Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation | |
| GB953960A (en) | Improvements in or relating to the production of compressed therapeutic tablets | |
| DE3766343D1 (en) | MEDICINAL PRODUCT CONTAINING IBUPROFEN AND ALUMINUM HYDROXIDE. | |
| EP0165696A3 (en) | Improved transdermal dosage form | |
| GB1171691A (en) | Lond-Acting Oral Carrier | |
| ATE158504T1 (en) | EFFORTABLE MIXTURES CONTAINING IBUPROFEN AND METHODS | |
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| IE781032L (en) | Pharmaceutical compositions | |
| GB1003065A (en) | An improved tablet and preparation thereof | |
| GB1427881A (en) | Mixtures containing nitroglycerin and polyvinyl-pyrrolidone | |
| GB1205019A (en) | Improvements in or relating to oral dosage forms | |
| HK134494A (en) | Substituted release azelastine containing medicaments | |
| GB2021409A (en) | Pharmaceutical composition | |
| GB1445995A (en) | Pharmaceutical preparations comprising n-4-2-5-chloro-2-metho xybenzamidoethyl-phenylsulphonyl-n-cyclohexylurea and salts thereof | |
| GB1202148A (en) | Pharmaceutical compositions | |
| DE2860724D1 (en) | Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them | |
| IL50938A (en) | 2-(9-substituted alkyl-6-purin-yl-amino)-and 2-(1-substituted alkyl-pyrazolo (3,4-d)pyrimidin-4-yl-amino)benzoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| GB922697A (en) | Coated vitamin preparations and a process for making them | |
| GB1442159A (en) | Pharmaceutical compositions containing paracetamol | |
| ES500670A0 (en) | PROCEDURE FOR PREPARING DRUGS WITH A PROGRAMMED RELEASE OF ACTIVE SUBSTANCE. | |
| SE317465B (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |